AstraZeneca
  • Bookmark This Page
  • Print This Page
  • Share with a Friend
Change Text Size
Change Text Size
Change Text Size
Change Text Size
Change Text Size

Asthma Screening Tool—help your patients’ parents convey their child's asthma symptoms

Asthma symptoms often seem like other respiratory problems. Furthermore, parents may not know how to speak to their child about asthma symptoms or report these symptoms to their health care team.

The Asthma Screening Tool contains questions about established or suspected asthma. While not intended to diagnose asthma, this form may enable your patients’ parents to better convey their child's asthma symptoms to you.

This form contains questions for patients with suspected or established asthma.

This form is not intended to be used to diagnose asthma.

Mark the choices that best describe how your child is feeling and the symptoms that your child has experienced.

Discuss any questions you may have with your child's doctor/healthcare provider.

1. Has your child ever been diagnosed with asthma? Yes No
1a. If yes, at what age was he or she       diagnosed?
1b. Do you believe he or she still has asthma? Yes No
2. Has your child ever been tested for allergies? Yes No
2a. If yes, date of allergy testing:
2b. Did he or she test positive? Yes No
2c. What allergies did he or she test positive       for?
3. Are there smokers in your house? Yes No
4. Is your child exposed to second-hand smoke? Yes No
5. What symptoms has your child experienced? Check all that apply.
Persistent coughing
Wheezing (a whistling sound while breathing)
Difficulty breathing and shortness of breath, especially during or       after activity
Chest tightness or complaints of chest hurting
6. What is the longest your child has experienced any of these symptoms?
Less than 1 month
1–6 months
7-12 months
More than 1 year
7. How often does your child experience coughing, wheezing, shortness of breath, chest tightness or complaints of chest hurting?
Less than or equal to 2 times a week
More than 2 times a week but less than 1 time a day
Every day
Continuously
8. When does your child experience coughing, wheezing, shortness of breath, or chest tightness? Check all that apply.
8a. During the day Yes No
8b. At night, waking him or her up Yes No
8c. During or right after exercising Yes No
9. What makes your child's symptoms worse? Check all that apply and fill in the blanks.
Smoke
Cold/flu
Prolonged laughter or crying
Animals
Cold air
Vigorous activity
Foods:
Dust
Pollen
Strong odors and sprays
Mold
10. In the past 2 weeks, have these symptoms kept your child from doing any activities? Yes No

If yes, what activities were they?
11. In the past few months, have these symptoms caused your child to miss school? Yes No
12. In the past few months, has your child had to go to the emergency room or hospital because of these symptoms? Yes No

If yes, please described what happened.
13. Please list all medicines, including over-the-counter medicines, that your child is currently taking, or has taken in the last month.
14. Does anyone else in your family have asthma, hay fever (allergic rhinitis), or eczema (atopic dermatitis)?

A NOTE TO PHYSICIANS: This form is intended to be used only as an adjunct to your history-taking of patients with suspected or established asthma. It should be discussed with your patient. (This form has not been validated as a diagnostic tool.)

“Next” Button
Learn about asthma screening events

Indication and Important Safety Information

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.

PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of acute bronchospasm.

Common adverse events reported in clinical trials, regardless of relationship to treatment, included respiratory infection, rhinitis, coughing, otitis media, viral infection, gastroenteritis, ear infection, oral thrush/candidiasis, and epistaxis.

Inhaled corticosteroids may cause a reduction in growth velocity. The long-term effect on final adult height is unknown.

PULMICORT RESPULES, like other inhaled corticosteroids, may impact the hypothalamic-pituitary-adrenal axis, especially in susceptible individuals, in young children, and in patients given high doses for prolonged periods.

Particular care is needed for patients who are transferred from systemically active corticosteroids to less systemically available corticosteroids, because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids (see WARNINGS in full Prescribing Information).

Patients taking immunosuppressant doses of corticosteroids should avoid exposure to infections such as chicken pox and measles.

[Please see accompanying full Prescribing Information (PDF).]